CLOCK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.884800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.537400E-01
Normal-vs-Stage2
4.748800E-01
Normal-vs-Stage3
5.471400E-01
Normal-vs-Stage4
2.534000E-01
Stage1-vs-Stage2
7.706600E-01
Stage1-vs-Stage3
1.093020E-01
Stage1-vs-Stage4
3.466400E-01
Stage2-vs-Stage3
1.903990E-01
Stage2-vs-Stage4
9.023500E-02
Stage3-vs-Stage4
1.585810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.007800E-01
Normal-vs-AfricanAmerican
3.400600E-01
Normal-vs-Asian
8.348000E-01
Caucasian-vs-AfricanAmerican
4.376800E-01
Caucasian-vs-Asian
3.709800E-01
AfricanAmerican-vs-Asian
2.291000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.906400E-01
Normal-vs-Female
4.894000E-01
Male-vs-Female
9.059400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.137200E-01
Normal-vs-Age(41-60Yrs)
2.875800E-01
Normal-vs-Age(61-80Yrs)
5.895000E-01
Normal-vs-Age(81-100Yrs)
9.453000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.791740E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.200600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.254200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.264100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.312000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.494000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.723400E-01
Normal-vs-Daily Drinker
9.974400E-01
Normal-vs-Weekly Drinker
5.436200E-01
Normal-vs-Occasional Drinker
3.656600E-01
Normal-vs-Social Drinker
3.908600E-01
Non Drinker-vs-Daily Drinker
5.574400E-01
Non Drinker-vs-Weekly Drinker
5.541800E-01
Non Drinker-vs-Occasional Drinker
9.881700E-02
Non Drinker-vs-Social Drinker
1.290190E-01
Daily Drinker-vs-Weekly Drinker
3.103400E-01
Daily Drinker-vs-Occasional Drinker
4.279800E-02
Daily Drinker-vs-Social Drinker
7.806300E-02
Weekly Drinker-vs-Occasional Drinker
2.462800E-01
Weekly Drinker-vs-Social Drinker
2.495400E-01
Occasional Drinker-vs-Social Drinker
8.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.031200E-01
Normal-vs-Grade 2
2.033800E-01
Normal-vs-Grade 3
1.906020E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.157000E-01
Grade 1-vs-Grade 3
4.663400E-01
Grade 1-vs-Grade 4
4.031200E-01
Grade 2-vs-Grade 3
3.227400E-01
Grade 2-vs-Grade 4
2.033800E-01
Grade 3-vs-Grade 4
1.906020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.242200E-01
Normal-vs-NonDiabetic
5.637200E-01
Diabetic-vs-NonDiabetic
3.313600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.876000E-01
Normal-vs-NoPancreatitis
5.664200E-01
Pancreatitis-vs-NoPancreatitis
8.667400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.399200E-01
Normal-vs-N1
4.535200E-01
N0-vs-N1
7.783800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.472400E-01
Normal-vs-TP53-NonMutant
4.761400E-01
TP53-Mutant-vs-TP53-NonMutant
4.498200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
